Analysts Set Larimar Therapeutics, Inc. (NASDAQ:LRMR) PT at $20.00
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) has been given a consensus rating of “Buy” by the nine ratings firms that are currently covering the stock, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price […]
More Stories
Firefighters Union Declines to Endorse Trump or Harris in Presidential Race
By Katabella Roberts With only weeks to go until the November election, the International Association of Fire Fighters (IAFF), a...
Costco Is Now Selling Platinum Bars and Coins: 5 Things You Should Know
By Jack Phillips Costco has started selling platinum bars and coins for its members in what appears to be an...
Port Strike Ends as Union Reaches Tentative Agreement
By Andrew Moran Tens of thousands of dock and port workers are heading back to work after their union and...
EVgo (NYSE:EVGO) Receives “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of EVgo (NYSE:EVGO – Free Report) in a report released on Monday...
Paychex (NASDAQ:PAYX) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS
Paychex (NASDAQ:PAYX – Get Free Report) issued its quarterly earnings results on Tuesday. The business services provider reported $1.16 EPS...
CDC Issues Warning on Overdose Risk From Fake Prescription Medicines Online
By Jack Phillips The U.S. Centers for Disease Control and Prevention (CDC) this week warned Americans of a potential overdose...